אסטרוגנוס ® 0.3 מ"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ESTROGENS CONJUGATED 0.3 MG

Commercializzato da:

SALOMON,LEVIN & ELSTEIN LTD

Codice ATC:

G03CA57

Forma farmaceutica:

TABLETS

Via di somministrazione:

PER OS

Prodotto da:

TEVA WOMEN'S HEALTH INC., USA

Gruppo terapeutico:

CONJUGATED ESTROGENS

Indicazioni terapeutiche:

Estrogenus tablets are indicated in the:1. Treatment of moderate to severe vasomotor symptoms associated with menopause. 2. Treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar and vaginal atrophy, associated with menopause. When prescribing solely for the treatment of moderate to severe vaginal dryness and pain with intercourse, topical vaginal products should be considered.

Data dell'autorizzazione:

2012-04-01